This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2w0j
From Proteopedia
(New page: '''Unreleased structure''' The entry 2w0j is ON HOLD until Paper Publication Authors: Lountos, G.T., Tropea, J.E., Zhang, D., Jobson, A.G., Pommier, Y., Shoemaker, R.H., Waugh, D.S. De...) |
|||
| Line 1: | Line 1: | ||
| - | + | {{Seed}} | |
| + | [[Image:2w0j.jpg|left|200px]] | ||
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_2w0j", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_2w0j| PDB=2w0j | SCENE= }} | ||
| - | + | ===CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR=== | |
| - | Description: Crystal structure of Chk2 in complex with NSC 109555, a specific inhibitor | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
| + | The line below this paragraph, {{ABSTRACT_PUBMED_19177354}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 19177354 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_19177354}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | 2W0J is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2W0J OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:19177354</ref><ref group="xtra">PMID:17616632</ref><references group="xtra"/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Non-specific serine/threonine protein kinase]] | ||
| + | [[Category: Jobson, A G.]] | ||
| + | [[Category: Lountos, G T.]] | ||
| + | [[Category: Pommier, Y.]] | ||
| + | [[Category: Shoemaker, R H.]] | ||
| + | [[Category: Tropea, J E.]] | ||
| + | [[Category: Waugh, D S.]] | ||
| + | [[Category: Zhang, D.]] | ||
| + | [[Category: Chk2 inhibitor]] | ||
| + | [[Category: Kinase]] | ||
| + | [[Category: Li-fraumeni syndrome]] | ||
| + | [[Category: Nucleotide-binding]] | ||
| + | [[Category: Oncology]] | ||
| + | [[Category: Serine/threonine-protein kinase]] | ||
| + | [[Category: Structure-assisted drug design]] | ||
| + | [[Category: Transferase]] | ||
| + | |||
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Feb 11 12:37:34 2009'' | ||
Revision as of 10:37, 11 February 2009
CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555, A SPECIFIC INHIBITOR
Template:ABSTRACT PUBMED 19177354
About this Structure
2W0J is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Lountos GT, Tropea JE, Zhang D, Jobson AG, Pommier Y, Shoemaker RH, Waugh DS. Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor. Protein Sci. 2009 Jan;18(1):92-100. PMID:19177354 doi:10.1002/pro.16
- Jobson AG, Cardellina JH 2nd, Scudiero D, Kondapaka S, Zhang H, Kim H, Shoemaker R, Pommier Y. Identification of a Bis-guanylhydrazone [4,4'-Diacetyldiphenylurea-bis(guanylhydrazone); NSC 109555] as a novel chemotype for inhibition of Chk2 kinase. Mol Pharmacol. 2007 Oct;72(4):876-84. Epub 2007 Jul 6. PMID:17616632 doi:10.1124/mol.107.035832
Page seeded by OCA on Wed Feb 11 12:37:34 2009
Categories: Homo sapiens | Non-specific serine/threonine protein kinase | Jobson, A G. | Lountos, G T. | Pommier, Y. | Shoemaker, R H. | Tropea, J E. | Waugh, D S. | Zhang, D. | Chk2 inhibitor | Kinase | Li-fraumeni syndrome | Nucleotide-binding | Oncology | Serine/threonine-protein kinase | Structure-assisted drug design | Transferase
